Scenario: 2021 Mastectomy found to have DCIS in RUOQ & RLOQ, Invasive ductal carcinoma in RUOQ Question: How would you code primary site? C504 UOQ C509 Breast NOS Answer: C504 UOQ Rationale: Breast Solid Tumor Rules Table 1:…
Scenario: You are working on a case and are stumped. Using your himagine email, you email one of your knowledgeable & friendly himagine auditors with the following question. Hi Friendly QA Auditor, I have a question about a case. Can…
Scenario: Endometrioid Adenocarcinoma pT3b pN0 treated with TAH/BSO + XRT 1/7/21 to 2/11/21, Whole pelvis RT w/ 6X/IMRT, 180 cGy x 25 fx to 45 Gy. 2/13/21 to 2/18/21, Vaginal cuff HDR brachytherapy via Ir-192 seeds, 600 cGy x 2…
Scenario: 08-27-2021 patient diagnosed with metastatic pancreatic carcinoma on CT scan. 08-27-2021 Med Onc Consult: Explained our concerns for pursuing aggressive measures for his cancer given his co-morbidities and frailty. Patient decided to make himself DNR with goals to transition…
Scenario: 02-20-2021 MRI Brain: Approximately 0.7 cm T2 hyperintense, hypoenhancing lesion in the central pituitary gland is suspicious for a pituitary microadenoma. There is minimal local mass effect without suprasellar extension. No other sellar/suprasellar abnormalities 04-21-2021 Office Visit: Hyperprolactinemia, Microprolactinoma 7 mm. Prolactin…
Scenario: 08-01-2021 Colon Polypectomy: invasive adenocarcinoma limited to the lamina propria, margin clear Physician stated, No further treatment needed AJCC Path Stage pTis cN0 cM0 Stage 0 Question: How will you assign behavior code? /3 /2 Answer: /3 …
Scenario: 08-05-2021 shave biopsy left chest: Clark Level IV Melanoma 08-05-2021 shave biopsy left back: Clark Level II Melanoma Question: How will you abstract? Single Primary Multiple Primary Answer: Single Rationale 2021 Cutaneous Melanoma Multiple Primary Rules Rule…
Scenario: 2021 Distal Esophagus Primary Treated with radiation DOSE SITE SUMMARY: 4500 cGy was delivered. The field superiorly was 1 cm superior to the carina, inferiorly included the celiac artery, as the gastric entry was the denser portion of the medial…
Below is a list of known corrections that need to be made to your copy of the CTR Guide to Coding Radiation Therapy Treatment in the STORE Version 3.0 February 2021 . The guide is only published once per year,…
Scenario: 2021 patient presents with metastatic prostate adenocarcinoma to the bones, receiving Xgeva. Question: Would you code the Xgeva to Hormone therapy? Yes No Answer: No Rationale: SEER*Rx Interactive Antineoplastic Drugs Database https://seer.cancer.gov/seertools/seerrx/ Xgeva Category Ancillary Agent Biologic therapy (BRM, immunotherapy) Subcategory PLEASE SEE IMPORTANT CODING INFORMATION IN REMARKS FIELD…